Nuvalent (NUVL) Free Cash Flow (2020 - 2026)
Nuvalent (NUVL) posted Free Cash Flow of -$92.4 million for Q1 2026, down 26.01% on a QoQ basis from -$73.3 million in Q4 2025, and down 68.55% year-over-year from -$293.8 million in Q1 2025.
Nuvalent (NUVL) Free Cash Flow (2020 - 2026) Analysis & Trends
Nuvalent's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$92.4 million for Q1 2026.
- Quarterly Free Cash Flow fell 68.55% year-over-year to -$92.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$312.8 million (down 53.48% YoY) and the FY2025 annual result came in at -$275.2 million, down 48.71% from the prior year.
- Free Cash Flow was -$92.4 million for Q1 2026 at Nuvalent, down from -$73.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$13.5 million in Q1 2022 and bottomed at -$92.4 million in Q1 2026.
- A 5-year average of -$42.2 million and a median of -$36.1 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 128.25% — and 2025, when it dropped 18.27%.
- Nuvalent's Free Cash Flow stood at -$17.8 million in 2022, then slumped by 69.91% to -$30.2 million in 2023, then slumped by 105.24% to -$62.0 million in 2024, then fell by 18.27% to -$73.3 million in 2025, then declined by 26.01% to -$92.4 million in 2026.
- Business Quant data shows NUVL's Free Cash Flow at -$92.4 million in Q1 2026, -$73.3 million in Q4 2025, and -$70.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.95 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | -92.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.40 Mn |
| Mar 31, 2026 | -92.40 Mn |
| Dec 31, 2025 | -73.33 Mn |
| Dec 31, 2025 | -73.33 Mn |
| Sep 30, 2025 | -70.46 Mn |
| Sep 30, 2025 | -70.46 Mn |
| Jun 30, 2025 | -76.60 Mn |
| Jun 30, 2025 | -76.60 Mn |
| Mar 31, 2025 | -54.82 Mn |
| Mar 31, 2025 | -54.82 Mn |
| Dec 31, 2024 | -62.00 Mn |
| Dec 31, 2024 | -62.00 Mn |
| Sep 30, 2024 | -45.82 Mn |
| Sep 30, 2024 | -45.82 Mn |
| Jun 30, 2024 | -41.16 Mn |
| Jun 30, 2024 | -41.16 Mn |
| Mar 31, 2024 | -36.09 Mn |
| Mar 31, 2024 | -36.09 Mn |
| Dec 31, 2023 | -30.21 Mn |
| Dec 31, 2023 | -30.21 Mn |